Biophysical Property and Broad Anti-HIV Activity of Albuvirtide, a 3-Maleimimidopropionic Acid-Modified Peptide Fusion Inhibitor
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Biophysical Property and Broad Anti-HIV Activity of Albuvirtide, a 3-Maleimimidopropionic Acid-Modified Peptide Fusion Inhibitor
Authors
Keywords
-
Journal
PLoS One
Volume 7, Issue 3, Pages e32599
Publisher
Public Library of Science (PLoS)
Online
2012-03-06
DOI
10.1371/journal.pone.0032599
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Molecular strategies to design an escape-proof antiviral therapy
- (2011) Ben Berkhout et al. ANTIVIRAL RESEARCH
- Inhibition of HIV-1 by Fusion Inhibitors
- (2010) Dirk Eggink et al. CURRENT PHARMACEUTICAL DESIGN
- Peptide-Based Inhibitors of the HIV Envelope Protein and Other Class I Viral Fusion Proteins
- (2010) Imke Steffen et al. CURRENT PHARMACEUTICAL DESIGN
- The Prevalence of Transmitted Antiretroviral Drug Resistance in Treatment-Naive HIV-Infected Individuals in China
- (2010) Lingjie Liao et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Crystal Structure of HIV-1 gp41 Including Both Fusion Peptide and Membrane Proximal External Regions
- (2010) Victor Buzon et al. PLoS Pathogens
- Crystal Structure and Size-Dependent Neutralization Properties of HK20, a Human Monoclonal Antibody Binding to the Highly Conserved Heptad Repeat 1 of gp41
- (2010) Charles Sabin et al. PLoS Pathogens
- An Albumin-Conjugated Peptide Exhibits Potent Anti-HIV Activity and Long In Vivo Half-Life
- (2009) D. Xie et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In vitro and in vivo study of an albumin-binding prodrug of doxorubicin that is cleaved by cathepsin B
- (2009) Khalid Abu Ajaj et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Peptides in the treatment of AIDS
- (2009) Fred Naider et al. CURRENT OPINION IN STRUCTURAL BIOLOGY
- Detailed Mechanistic Insights into HIV-1 Sensitivity to Three Generations of Fusion Inhibitors
- (2009) Dirk Eggink et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Mutation L33M in the HR1 region of HIV-1 gp41 may play a role in T20 resistance
- (2009) Huihui Chong et al. JOURNAL OF CLINICAL VIROLOGY
- Addition of a cholesterol group to an HIV-1 peptide fusion inhibitor dramatically increases its antiviral potency
- (2009) P. Ingallinella et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- SC29EK, a Peptide Fusion Inhibitor with Enhanced -Helicity, Inhibits Replication of Human Immunodeficiency Virus Type 1 Mutants Resistant to Enfuvirtide
- (2008) T. Naito et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Electrostatically constrained α-helical peptide inhibits replication of HIV-1 resistant to enfuvirtide
- (2008) Hiroki Nishikawa et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Design and Evaluation of Sifuvirtide, a Novel HIV-1 Fusion Inhibitor
- (2008) Yuxian He et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Albumin-conjugated C34 Peptide HIV-1 Fusion Inhibitor
- (2008) Cheryl A. Stoddart et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Docetaxel–Albumin Conjugates: Preparation, In Vitro Evaluation and Biodistribution Studies
- (2008) Farnaz Esmaeili et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Selection of T1249-Resistant Human Immunodeficiency Virus Type 1 Variants
- (2008) D. Eggink et al. JOURNAL OF VIROLOGY
- Conserved Salt Bridge between the N- and C-Terminal Heptad Repeat Regions of the Human Immunodeficiency Virus Type 1 gp41 Core Structure Is Critical for Virus Entry and Inhibition
- (2008) Y. He et al. JOURNAL OF VIROLOGY
- Identification of a Critical Motif for the Human Immunodeficiency Virus Type 1 (HIV-1) gp41 Core Structure: Implications for Designing Novel Anti-HIV Fusion Inhibitors
- (2008) Y. He et al. JOURNAL OF VIROLOGY
- The Challenge of HIV-1 Subtype Diversity
- (2008) Barbara S. Taylor et al. NEW ENGLAND JOURNAL OF MEDICINE
- Potent HIV fusion inhibitors against Enfuvirtide-resistant HIV-1 strains
- (2008) Y. He et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation